Metropolis Healthcare Limited is a leading diagnostics chain in India, with a network of over 200 labs, over 4500 collection points, and over 25000 accredited doctors. It is one of the largest chain of diagnostic centers in India and provides a wide range of clinical laboratory tests and services.
Metropolis is ISO 15189 and NABL accredited and is also a CAP-accredited laboratory. The company is committed to providing quality healthcare services, at affordable prices to its customers. It is continuously innovating and introducing new technologies and processes, to help improve the quality of healthcare services provided.
Metropolis Healthcare has been listed on the National Stock Exchange of India since July 2018.
The company’s stock price steadily increased since its listing up to December 2021, but since then the share price has been in correction mode.
As of November 7, 2023, Metropolis Healthcare share price is trading at Rs. 1,519 and has a market capitalization of Rs. 7,781 crores.
Metropolis Healthcare Q2 FY2024 Financial Performance Overview
- Metropolis Healthcare reported a noticeable 11.9% decline in net profit, which fell to Rs 35.5 crore during the second quarter of the financial year.
- In contrast, the company’s revenue displayed a modest growth of 2.7%, reaching Rs 308.5 crore.
- However, the EBITDA figure saw a reduction, decreasing to Rs 74.8 crore, and the EBITDA margin contracted from 26.3% to 24.3%.
- On a positive note, the core business segment witnessed a robust 13% growth in revenue year-on-year.
- Likewise, the B2C revenue experienced significant growth, marking an increase of approximately 15%.
- Notably, the premium wellness segment emerged as the standout performer, demonstrating the fastest growth in the second quarter of FY24.
- Meanwhile, the company’s gross debt as of September 30, 2023, was estimated to be around Rs 44 crore.
How to buy Metropolis Healthcare Shares in India?
| When | Maximum Price | Minimum Price |
| November 2023 | ₹1,640.52 | ₹1,426.54 |
| December 2023 | ₹1,694.66 | ₹1,473.61 |
In November 2023, Metropolis Healthcare’s share price showed a range with a maximum value of ₹1,640.52 and a minimum of ₹1,426.54. As the year approached its end in December 2023, the share price was projected to have a maximum of ₹1,694.66 and a minimum of ₹1,473.61.
These price targets indicate a potential bullishness in the company’s stock value. As of November 7th, 2023, the current share price stood at ₹1,519.
Considering this, Metropolis Healthcare had a market capitalization of ₹7,781 crore.
| When | Maximum Price | Minimum Price |
| January 2024 | ₹1,729.24 | ₹1,503.69 |
| February 2024 | ₹1,764.53 | ₹1,534.38 |
| March 2024 | ₹1,800.54 | ₹1,565.69 |
| April 2024 | ₹1,748.10 | ₹1,520.09 |
| May 2024 | ₹1,722.27 | ₹1,497.62 |
| June 2024 | ₹1,784.27 | ₹1,551.54 |
| July 2024 | ₹1,766.43 | ₹1,536.02 |
| August 2024 | ₹1,837.08 | ₹1,597.46 |
| September 2024 | ₹1,910.57 | ₹1,661.36 |
| October 2024 | ₹1,873.10 | ₹1,628.79 |
| November 2024 | ₹1,929.30 | ₹1,677.65 |
| December 2024 | ₹1,977.53 | ₹1,719.59 |
Metropolis Healthcare’s share price projections for 2024 reveal a range of expectations throughout the year. In January 2024, the share price is estimated to fluctuate between a maximum of ₹1,729.24 and a minimum of ₹1,503.69. The pattern continues through the year, with anticipated maximum and minimum prices for each month.
By December 2024, the maximum share price is expected to reach ₹1,977.53, while the minimum is projected to be ₹1,719.59. These forecasts offer investors and market observers insights into potential price movements. It’s important to note that these figures are subject to various market factors and should be used as a reference for investment decisions.
Metropolis Healthcare Price Target 2025
| When | Maximum Price | Minimum Price |
| January 2025 | ₹2,017.08 | ₹1,551.60 |
| February 2025 | ₹2,068.80 | ₹1,591.38 |
| March 2025 | ₹2,149.48 | ₹1,653.45 |
| April 2025 | ₹2,107.34 | ₹1,621.03 |
| May 2025 | ₹2,045.96 | ₹1,573.81 |
| June 2025 | ₹2,138.03 | ₹1,644.64 |
| July 2025 | ₹2,096.10 | ₹1,612.39 |
| August 2025 | ₹2,160.93 | ₹1,662.25 |
| September 2025 | ₹2,236.56 | ₹1,720.43 |
| October 2025 | ₹2,294.71 | ₹1,765.17 |
| November 2025 | ₹2,352.08 | ₹1,809.29 |
| December 2025 | ₹2,410.88 | ₹1,854.53 |
Metropolis Healthcare’s share price targets for 2025 depict a gradual and optimistic upward trend. In January 2025, the maximum share price is projected at ₹2,017.08, with a minimum of ₹1,551.60, suggesting potential volatility.
As the year progresses, the estimates continue to show growth, with a maximum of ₹2,410.88 and a minimum of ₹1,854.53 in December 2025. These forecasts indicate an overall positive sentiment and confidence in the company’s performance and prospects.
| Year | Maximum Price | Minimum Price |
| 2026 | ₹2,531.43 | ₹1,772.00 |
| 2027 | ₹2,784.57 | ₹1,949.20 |
| 2028 | ₹3,898.40 | ₹1,949.20 |
| 2029 | ₹3,375.24 | ₹1,687.62 |
| 2030 | ₹4,387.81 | ₹3,071.47 |
The projected share price targets for Metropolis Healthcare from 2026 to 2030 indicate a potentially exciting period of growth. In 2026, the stock is forecasted to reach a maximum price of ₹2,531.43, with a minimum of ₹1,772.00, showing a range of expectations. This trend continues into 2027, with an estimated maximum price of ₹2,784.57 and a minimum of ₹1,949.20.
The subsequent years, 2028 and 2029, suggest even more substantial potential gains. In 2028, the share price target is set at ₹3,898.40, and in 2029, it is estimated to fluctuate between a maximum of ₹3,375.24 and a minimum of ₹1,687.62.
Looking further ahead to 2030, the share price target is remarkably optimistic, with a maximum of ₹4,387.81 and a minimum of ₹3,071.47.
These projections indicate a robust and bullish outlook for Metropolis Healthcare over the next five years, driven by various factors such as company performance, industry dynamics, and market sentiment. However, it’s crucial to remember that these are forecasts and subject to change as market conditions evolve. Investors should conduct thorough research and consider these estimates as part of their investment decisions.
Metropolis Healthcare Financial Condition: Last 5 years
| Year | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Sales (in crore INR) |
761 | 856 | 998 | 1,228 | 1,148 |
| Expenses (in crore INR) |
559 | 619 | 708 | 880 | 860 |
| Operating Profit (in crore INR) |
203 | 237 | 290 | 348 | 288 |
| OPM % | 27% | 28% | 29% | 28% | 25% |
| Other Income (in crore INR) |
8 | -17 | 12 | 34 | 15 |
| Interest (in crore INR) |
4 | 13 | 12 | 25 | 27 |
| Depreciation (in crore INR) |
20 | 39 | 46 | 63 | 89 |
| Profit before tax (in crore INR) |
187 | 169 | 244 | 293 | 188 |
| Tax % | 34% | 24% | 25% | 27% | 24% |
| Net Profit (in crore INR) |
124 | 128 | 183 | 215 | 143 |
| EPS in Rs | 23.94 | 25.15 | 35.82 | 41.85 | 27.90 |
| Dividend Payout % | 55% | 32% | 22% | 19% | 29% |
In the past five years, from 2019 to 2023, the financial performance of Metropolis Healthcare has shown varying trends. The sales figures exhibited an upward trajectory, starting at 761 crores in 2019, peaking at 1,228 crores in 2022, and slightly decreasing to 1,148 crores in 2023. However, expenses also increased over the same period, reaching a peak of 880 crores in 2022. The operating profit of Metropolis Healthcare followed a similar pattern, reaching its highest point of 348 crores in 2022.
Metropolis Healthcare’s operating profit margin (OPM %) remained relatively stable, fluctuating between 25% and 29% throughout the five years. Other income, interest, and depreciation expenses also experienced variations. The net profit showed a growth trend, reaching 215 crores in 2022, but decreased to 143 crores in 2023. The earnings per share (EPS) ranged from 23.94 to 41.85 rupees during this period. The dividend payout percentage fluctuated between 19% and 55%, reflecting varying dividend distribution practices.
FAQs
Will Metropolis Healthcare’s stock price grow in 2023?
Metropolis Healthcare could reach ₹1,694.66 by the end of 2023
What is the Market Cap of Metropolis Healthcare?
Metropolis Healthcare has a market capitalization of ₹ 7,781 Cr. as of November 7, 2023.
The share price of Metropolis Healthcare is expected to reach Rs. 1,729.24 – 1,977.53 in 2024, based on the company’s current performance and growth prospects.
Can Metropolis Healthcare reach 3000 INR?
At this time, it is difficult to predict whether Metropolis Healthcare will reach 3000 INR in the future. However, based on the company’s past performance and growth prospects, it is likely that the stock price will continue to grow in the coming years.
2025 is expected to be a bullish year for Metropolis. Metropolis Healthcare share price prediction for 2025 suggests it could be trading between ₹2,410.88 to ₹1,621.03
Metropolis Healthcare’s share price prediction for 2030 suggests it could be trading between ₹4,387.81(maximum) to ₹3,071.47.
CONCLUSION: Should you buy Metropolis Healthcare in 2023?
Metropolis Healthcare is among India’s top diagnostic companies, boasting over 200 labs and collaborations with more than 25,000 doctors. They have recently made a significant investment of Rs. 20 Crore to enhance their services, the results of which are anticipated to show in the coming times. A testament to their potential, Marcellus Investment Managers, steered by Saurabh Mukherjea, has added Metropolis to their esteemed Little Champs Portfolio.
Over the next couple of years, Metropolis is setting its sights on expanding its direct-to-customer business. Based on their current trajectory and future plans, experts predict that the company’s share price might climb to Rs. 3,137.48 by 2025. If the company continues on this upward trend, it might even reward its shareholders with bonus shares.
Given all these positive indicators, it seems wise for investors to consider adding Metropolis Healthcare to their portfolios, as it shows potential to be a lucrative investment in the foreseeable future.
Another company in the hospital industry you may want to look into is Rainbow Hospital.
Disclaimer: The projected share price target for Metropolis Healthcare from 2023 to 2030 is based on opinions and should not be construed as financial advice. Please conduct your own due diligence or consult with a financial advisor before considering an investment in Metropolis Healthcare shares. We are not affiliated with SEBI nor are we a registered financial advisor.
What did we learn?
- 1 Metropolis Healthcare Q2 FY2024 Financial Performance Overview
- 2 How to buy Metropolis Healthcare Shares in India?
- 3 Metropolis Healthcare Limited Share Price Prediction 2023-2030
- 4 Metropolis Healthcare Financial Condition: Last 5 years
- 5 FAQs
- 5.1 Will Metropolis Healthcare’s stock price grow in 2023?
- 5.2 What is the Market Cap of Metropolis Healthcare?
- 5.3 What do you anticipate the share price of Metropolis Healthcare to be in the year 2024?
- 5.4 Can Metropolis Healthcare reach 3000 INR?
- 5.5 What is Metropolis Healthcare Share Price Prediction 2025?
- 5.6 What is Metropolis Healthcare Share Price Target 2030?
- 6 CONCLUSION: Should you buy Metropolis Healthcare in 2023?
Linkedin
